Deferred Income Tax Liabilities, Net of Keenova Therapeutics plc from 25 Dec 2020 to 27 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: Keenova Therapeutics plc quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 25 Dec 2020 to 27 Dec 2024.
Keenova Therapeutics plc Deferred Income Tax Liabilities, Net for the quarter ending 27 Dec 2024 was $100,000.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$100,000	+$100,000		27 Dec 2024	10-K	13 Mar 2025	2024	FY
Q4 2023	$0	-$300,000	-100%	29 Dec 2023	10-K	13 Mar 2025	2024	FY
Q4 2022	$300,000	-$20,600,000	-99%	30 Dec 2022	10-K	26 Mar 2024	2023	FY
Q4 2021	$20,900,000	-$59,700,000	-74%	31 Dec 2021	10-K	03 Mar 2023	2022	FY
Q4 2020	$80,600,000			25 Dec 2020	10-K	15 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.